Results 141 to 150 of about 1,158 (177)
Some of the next articles are maybe not open access.
Teduglutide for the treatment of short bowel syndrome
Drugs of Today, 2013Glucagon-like peptide 2 (GLP-2) decreases gastric and intestinal motility, reduces gastric secretions, promotes intestinal growth and improves post-resection structural and functional adaptation in short bowel syndrome (SBS). Teduglutide, an analogue of GLP-2, has a prolonged half-life and provides intestinotrophic effects with once-daily subcutaneous ...
openaire +2 more sources
Long-Term Outcomes With Teduglutide From a Single Center
Journal of Parenteral and Enteral Nutrition, 2021Carol Semrad +2 more
exaly
Teduglutide in short bowel syndrome patients: A way back to normal life?
Journal of Parenteral and Enteral Nutrition, 2022Judith Stift, Felix Harpain, Anton Stift
exaly

